TitleProduct

Covid 19 Antigen Saliva Rapid Test

  • Price:

    Negotiable

  • minimum:

  • Total supply:

  • Delivery term:

    The date of payment from buyers deliver within days

  • seat:

    Beijing

  • Validity to:

    Long-term effective

  • Last update:

    2021-06-28 00:31

  • Browse the number:

    244

Send an inquiries

Company Profile

Hangzhou Lysun Biotechnology Co., Ltd

By certification [File Integrity]

Contact:lainsheng(Mr.)  

Email:

Telephone:

Phone:

Area:Beijing

Address:Beijing

Website:http://www.lysunbio.com/ http://lainsheng.wedding02.com/

PRODUCT DETAILS

Specification

Product name

Covid 19 Antigen Saliva Rapid Test

Item type

COV-201

Specimens

Saliva

Specificity

100%

Sensitivity

94.94%

Packing Specification

1 kit/ box, 5 kits / box, 25 kits / box

Size

160*55*20mm

1 kit/ box

190*125*30mm

5 kits / box

190*125*70mm

25 kits / box

Shelf life

2 years

Test Time

Waiting about 15 minutes

Service condition

The kit should be stored at 2-30°C


Product introduction

The Covid 19 Antigen Saliva Rapid Test (Colloidal Gold) is a rapid visual immunoassay for the qualitative, presumptive detection of COVID-19 antigens from saliva. The test is intended for use as an aid in the rapid differential diagnosis of acute COVID-19 virus infection.

The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.


Advantages

Advantages of Covid 19 Antigen Saliva Rapid Test:

-There are three specifications to choose from

-Factory direct sales, affordable

-Support a variety of sampling methods to meet different needs


Company profile

Hangzhou Lysun Biotechnology Co., LTD., founded in 2018, has a strong RESEARCH and development team. Key members of the team have over 20 years of experience in the IVD industry. Since its establishment, the company has developed rapidly, so far, we have more than 10 patented technologies, and have a white list of several European countries. Our vision is to become the industry leader, our mission is to provide customers with the most accurate and affordable POCT products.


Certificate

http://www.lysunbio.com/